FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012137311> ?p ?o ?g. }

• W2012137311 endingPage "3275" @default.
• W2012137311 startingPage "3269" @default.
• W2012137311 abstract "The aim of this manuscript was to report the risk of incident peripheral arterial disease (PAD) in a large randomized clinical trial that enrolled participants with stable coronary artery disease and type 2 diabetes and compare the risk between assigned treatment arms.The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial randomly assigned participants to insulin sensitization (IS) therapy versus insulin-providing (IP) therapy for glycemic control. Results showed similar 5-year mortality in the two glycemic treatment arms. In secondary analyses reported here, we examine the effects of treatment assignment on the incidence of PAD. A total of 1,479 BARI 2D participants with normal ankle-brachial index (ABI) (0.91-1.30) were eligible for analysis. The following PAD-related outcomes are evaluated in this article: new low ABI≤0.9, a lower-extremity revascularization, lower-extremity amputation, and a composite of the three outcomes.During an average 4.6 years of follow-up, 303 participants experienced one or more of the outcomes listed above. Incidence of the composite outcome was significantly lower among participants assigned to IS therapy than those assigned to IP therapy (16.9 vs. 24.1%; P<0.001). The difference was significant in time-to-event analysis (hazard ratio 0.66 [95% CI 0.51-0.83], P<0.001) and remained significant after adjustment for in-trial HbA1c (0.76 [0.59-0.96], P=0.02).In participants with type 2 diabetes who are free from PAD, a glycemic control strategy of insulin sensitization may be the preferred therapeutic strategy to reduce the incidence of PAD and subsequent outcomes." @default.
• W2012137311 created "2016-06-24" @default.
• W2012137311 creator A5008504819 @default.
• W2012137311 creator A5008717215 @default.
• W2012137311 creator A5013083237 @default.
• W2012137311 creator A5018100405 @default.
• W2012137311 creator A5030715915 @default.
• W2012137311 creator A5032504764 @default.
• W2012137311 creator A5049309607 @default.
• W2012137311 creator A5061646942 @default.
• W2012137311 creator A5073170746 @default.
• W2012137311 date "2013-09-14" @default.
• W2012137311 modified "2023-10-13" @default.
• W2012137311 title "Favorable Effects of Insulin Sensitizers Pertinent to Peripheral Arterial Disease in Type 2 Diabetes" @default.
• W2012137311 cites W1526927233 @default.
• W2012137311 cites W1536082922 @default.
• W2012137311 cites W172609984 @default.
• W2012137311 cites W1967749122 @default.
• W2012137311 cites W1969425941 @default.
• W2012137311 cites W1970185541 @default.
• W2012137311 cites W2001041741 @default.
• W2012137311 cites W2003968541 @default.
• W2012137311 cites W2005638077 @default.
• W2012137311 cites W2010579141 @default.
• W2012137311 cites W2013077255 @default.
• W2012137311 cites W2014179250 @default.
• W2012137311 cites W2014336636 @default.
• W2012137311 cites W2019464320 @default.
• W2012137311 cites W2022036486 @default.
• W2012137311 cites W2022986947 @default.
• W2012137311 cites W2031659960 @default.
• W2012137311 cites W2033209114 @default.
• W2012137311 cites W2035840172 @default.
• W2012137311 cites W2039955829 @default.
• W2012137311 cites W2087477127 @default.
• W2012137311 cites W2095219849 @default.
• W2012137311 cites W2100049802 @default.
• W2012137311 cites W2101065836 @default.
• W2012137311 cites W2108541380 @default.
• W2012137311 cites W2110664743 @default.
• W2012137311 cites W2112715147 @default.
• W2012137311 cites W2118860915 @default.
• W2012137311 cites W2125588985 @default.
• W2012137311 cites W2132692865 @default.
• W2012137311 cites W2144829836 @default.
• W2012137311 cites W2150215516 @default.
• W2012137311 cites W2158666727 @default.
• W2012137311 cites W2168501132 @default.
• W2012137311 cites W2169226612 @default.
• W2012137311 cites W2315630371 @default.
• W2012137311 cites W4234590128 @default.
• W2012137311 cites W4236938366 @default.
• W2012137311 cites W4243656112 @default.
• W2012137311 cites W4376596185 @default.
• W2012137311 doi "https://doi.org/10.2337/dc12-2265" @default.
• W2012137311 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3781574" @default.
• W2012137311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23735723" @default.
• W2012137311 hasPublicationYear "2013" @default.
• W2012137311 type Work @default.
• W2012137311 sameAs 2012137311 @default.
• W2012137311 citedByCount "26" @default.
• W2012137311 countsByYear W20121373112013 @default.
• W2012137311 countsByYear W20121373112014 @default.
• W2012137311 countsByYear W20121373112015 @default.
• W2012137311 countsByYear W20121373112016 @default.
• W2012137311 countsByYear W20121373112017 @default.
• W2012137311 countsByYear W20121373112018 @default.
• W2012137311 countsByYear W20121373112019 @default.
• W2012137311 countsByYear W20121373112020 @default.
• W2012137311 countsByYear W20121373112021 @default.
• W2012137311 countsByYear W20121373112022 @default.
• W2012137311 countsByYear W20121373112023 @default.
• W2012137311 crossrefType "journal-article" @default.
• W2012137311 hasAuthorship W2012137311A5008504819 @default.
• W2012137311 hasAuthorship W2012137311A5008717215 @default.
• W2012137311 hasAuthorship W2012137311A5013083237 @default.
• W2012137311 hasAuthorship W2012137311A5018100405 @default.
• W2012137311 hasAuthorship W2012137311A5030715915 @default.
• W2012137311 hasAuthorship W2012137311A5032504764 @default.
• W2012137311 hasAuthorship W2012137311A5049309607 @default.
• W2012137311 hasAuthorship W2012137311A5061646942 @default.
• W2012137311 hasAuthorship W2012137311A5073170746 @default.
• W2012137311 hasBestOaLocation W20121373111 @default.
• W2012137311 hasConcept C120665830 @default.
• W2012137311 hasConcept C121332964 @default.
• W2012137311 hasConcept C126322002 @default.
• W2012137311 hasConcept C134018914 @default.
• W2012137311 hasConcept C141071460 @default.
• W2012137311 hasConcept C168563851 @default.
• W2012137311 hasConcept C207103383 @default.
• W2012137311 hasConcept C2776204877 @default.
• W2012137311 hasConcept C2777180221 @default.
• W2012137311 hasConcept C2777466421 @default.
• W2012137311 hasConcept C2778213512 @default.
• W2012137311 hasConcept C2779306644 @default.
• W2012137311 hasConcept C2779464278 @default.
• W2012137311 hasConcept C2780326628 @default.
• W2012137311 hasConcept C2780473172 @default.

• next